Latest news
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 12:27:37 GMTApnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 07:00:00 GMTZepto eyes Rs 1,000 crore pre-IPO funding, listing schedule moves back by weeks - The New Indian ExpressThe New Indian Express · Thu, 30 Jul 2026 07:00:00 GMTVarsal Tech To Shift Business Model With IPO Funding (VAT) - Seeking AlphaSeeking Alpha · Thu, 30 Jul 2026 07:00:00 GMT